Emorfazone (PH011085) is a small molecule compound exhibiting analgesic properties. It has been investigated in preclinical research for its potential to modulate pain pathways, with studies including both in vitro assays and in vivo animal models of nociception.
Molekulargewicht:
239.27
Reinheit:
99.89% (May vary between batches)
CAS Nummer:
[38957-41-4]
Formel:
C11H17N3O3
Target-Kategorie:
Others,Bradykinin Receptor
Anwendungsbeschreibung:
Solubility: DMSO:55 mg/mL (229.87 mM)
* Mehrwertsteuer und Versandkosten nicht enthalten. Irrtümer und Preisänderungen vorbehalten